Výsledky vyhledávání - "Marta Español-Rego"

Akademický článek

Practical aspects of chimeric antigen receptor T-cell administration: From commercial to point-of-care manufacturing

Autor: Nuria Martinez-Cibrian, Marta Español-Rego, Mariona Pascal, Julio Delgado, Valentín Ortiz-Maldonado

Publikováno v: Frontiers in Immunology, Vol 13 (2022)

Chimeric antigen receptor T-cells targeting the CD19 antigen have achieved impressive results in patients with relapsed/refractory (R/R) B-cell malignancies, leading to their approval in the European Union and other jurisdictions. In Spain, the 100%

Externí odkaz: https://doaj.org/article/1b4381fb80f14eb9b8ac5d72d310c398

Zobrazit plný text záznamu

Akademický článek

Results of ARI-0001 CART19 Cells in Patients With Chronic Lymphocytic Leukemia and Richter’s Transformation

Publikováno v: Frontiers in Oncology, Vol 12 (2022)

CART19 cells are emerging as an alternative therapy for patients with chronic lymphocytic leukemia (CLL). Here we report the outcome of nine consecutive patients with CLL treated with ARI-0001 CART19 cells, six of them with Richter’s transformation

Externí odkaz: https://doaj.org/article/6181d522f8dc416998fbf994486c46d2

Zobrazit plný text záznamu

Akademický článek

Post-mortem neuropathologic examination of a 6-case series of CAR T-cell treated patients

Publikováno v: Free Neuropathology, Vol 3 (2022)

Introduction: Chimeric antigen receptor (CAR) T-cell therapy is a promising immunotherapy for the treatment of refractory hematopoietic malignancies. Adverse events are common, and neurotoxicity is one of the most important. However, the physiopathol

Externí odkaz: https://doaj.org/article/00d9ba14db9a4b1fbb3ea1b2032c2a8c

Zobrazit plný text záznamu

Akademický článek

Vaccines for Non-Viral Cancer Prevention

Autor: Cristina Bayó, Gerhard Jung, Marta Español-Rego, Francesc Balaguer, Daniel Benitez-Ribas

Publikováno v: International Journal of Molecular Sciences, Vol 22, Iss 20, p 10900 (2021)

Cancer vaccines are a type of immune therapy that seeks to modulate the host’s immune system to induce durable and protective immune responses against cancer-related antigens. The little clinical success of therapeutic cancer vaccines is generally

Externí odkaz: https://doaj.org/article/4ad0d603f399495aa9d066681636fc95

Zobrazit plný text záznamu

Akademický článek

Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations

Autor: Raquel Ruiz-García, Eugenia Martínez-Hernández, Milagros García-Ormaechea, Marta Español-Rego, Lidia Sabater, Luis Querol, Isabel Illa, Josep Dalmau, Francesc Graus

Publikováno v: Frontiers in Immunology, Vol 10 (2019)

SOX1 autoantibodies are considered markers of small cell lung cancer (SCLC) and paraneoplastic neurological syndromes (PNS) and are usually determined by commercial line blot in many clinical services. Recent studies suggested that SOX1 autoantibodie

Externí odkaz: https://doaj.org/article/9b3399466cb04c9a837d3b5176ad6268

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání